HCA Healthcare’s (NYSE:HCA) “Outperform” Rating Reaffirmed at Credit Suisse Group

Credit Suisse Group reiterated their outperform rating on shares of HCA Healthcare (NYSE:HCA) in a research report report published on Tuesday, December 26th. The brokerage currently has a $25.00 price objective on the stock.

Several other research analysts have also weighed in on the company. Robert W. Baird reaffirmed a buy rating on shares of HCA Healthcare in a research report on Thursday, September 28th. ValuEngine raised HCA Healthcare from a hold rating to a buy rating in a research report on Monday, October 2nd. Royal Bank of Canada reaffirmed an outperform rating and issued a $90.00 target price on shares of HCA Healthcare in a research report on Thursday, October 19th. SunTrust Banks set a $105.00 price objective on HCA Healthcare and gave the company a buy rating in a report on Thursday, December 21st. Finally, BMO Capital Markets initiated coverage on HCA Healthcare in a report on Monday, October 16th. They set an outperform rating and a $90.00 price objective on the stock. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have issued a buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of $88.70.

Shares of HCA Healthcare (NYSE:HCA) opened at $88.80 on Tuesday. HCA Healthcare has a fifty-two week low of $71.18 and a fifty-two week high of $91.03. The company has a market capitalization of $30,791.95, a price-to-earnings ratio of 12.63, a PEG ratio of 1.17 and a beta of 0.55. The company has a current ratio of 1.68, a quick ratio of 1.41 and a debt-to-equity ratio of -6.46.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.21. The firm had revenue of $10.70 billion during the quarter, compared to the consensus estimate of $10.70 billion. HCA Healthcare had a negative return on equity of 47.16% and a net margin of 6.13%. The business’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the prior year, the business earned $1.45 EPS. sell-side analysts anticipate that HCA Healthcare will post 6.56 EPS for the current year.

In other news, insider Michael S. Cuffe sold 2,400 shares of HCA Healthcare stock in a transaction on Friday, December 15th. The stock was sold at an average price of $86.63, for a total value of $207,912.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of HCA Healthcare stock in a transaction on Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the sale, the insider now directly owns 12,476 shares of the company’s stock, valued at $973,128. The disclosure for this sale can be found here. Insiders have sold a total of 22,700 shares of company stock valued at $1,773,872 in the last 90 days. 2.90% of the stock is owned by corporate insiders.

Hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in shares of HCA Healthcare by 0.7% in the second quarter. Vanguard Group Inc. now owns 19,718,250 shares of the company’s stock valued at $1,719,431,000 after purchasing an additional 141,258 shares in the last quarter. Glenview Capital Management LLC lifted its holdings in shares of HCA Healthcare by 2.6% in the second quarter. Glenview Capital Management LLC now owns 14,899,289 shares of the company’s stock valued at $1,299,218,000 after purchasing an additional 384,024 shares in the last quarter. Longview Partners Guernsey LTD lifted its holdings in shares of HCA Healthcare by 22.6% in the third quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock valued at $886,247,000 after purchasing an additional 2,053,701 shares in the last quarter. LSV Asset Management lifted its holdings in shares of HCA Healthcare by 5.5% in the second quarter. LSV Asset Management now owns 3,907,939 shares of the company’s stock valued at $340,772,000 after purchasing an additional 203,290 shares in the last quarter. Finally, APG Asset Management N.V. lifted its holdings in shares of HCA Healthcare by 141.4% in the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock valued at $272,467,000 after purchasing an additional 2,005,193 shares in the last quarter. Hedge funds and other institutional investors own 75.34% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.thelincolnianonline.com/2018/01/14/hca-healthcare-hca-receives-outperform-rating-from-credit-suisse-group-updated-updated.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply